
News
Merck: The U.S. Food and Drug Administration has accepted the priority review of Keytruda based on the KEYNOTE - B96 trial data

Merck: The U.S. Food and Drug Administration has accepted the priority review of Keytruda based on the KEYNOTE - B96 trial data